PML and nonpapillary renal cell carcinoma: Forty-eight hours of treatment of ccRCC cells with the standard dose of 1 μM ATO and lower concentrations (0.25 and 0.5 μM) revealed sizable PML degradation in all cell lines (Fig. 7A–D, right panels).